Serdemetan T2243
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Serdemetan is an orally bioavailable HDM2 antagonist with potential antineoplastic activity.
CAS nr:
881202-45-5
Purity:
98%
Molecular Weight:
328,42
SMILES:
c1ccc2c(c1)c(CCNc1ccc(cc1)Nc1ccncc1)c[nH]2
Formula:
C21H20N4
Pathway:
Apoptosis,Ubiquitination,Apoptosis,Apoptosis
Target:
Mdm2,E1/E2/E3 Enzyme,Apoptosis,p53
